Johnson & Johnson stock holds near a record high as valuation rises

Published on 09/22/2026 at 12:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson stock closed at USD 269.47 on September 21, 2026, up 30.2 percent year to date. Second quarter EPS reached USD 2.90 versus USD 2.85 expected.

Modern hospital operating room with robotic surgical arms positioned above a draped patient, surgeons in blue sterile gowns monitoring vital-sign and anatomy screens, bright overhead surgical lighting, stainless steel instrument trays in the foreground — Johnson und US4781601046 zeigen modernen Krankenhaus OP mit Robotik Chirurgie und medizinischen Bildschirmen, Illustration mit AI erstellt.

Johnson & Johnson (US4781601046) closed at USD 269.47 on the NYSE on September 21, 2026, after gaining 30.2 percent since the start of the year. The healthcare group enters its next earnings checkpoint with second quarter 2026 EPS of USD 2.90, above the USD 2.85 consensus estimate.

Second quarter earnings set the benchmark

Johnson & Johnson generated USD 25.31 billion in revenue and USD 5.53 billion in earnings in the second quarter of fiscal year 2026, according to Ad-hoc News on September 20, 2026. The resulting profit margin was about 21.86 percent, while EPS increased 4.7 percent from USD 2.77 in the year-earlier quarter.

The comparison with expectations is also material: second quarter EPS exceeded the USD 2.85 estimate by USD 0.05, or about 1.8 percent. That gives the next report a clear reference point, particularly for revenue growth, margins and guidance.

Valuation now limits the margin for error

Johnson & Johnson had a market capitalization of USD 653.65 billion on September 21, 2026, according to GuruFocus. A separate valuation model cited by the same outlet placed fair value at USD 193.54 against a share price of USD 272.19 on September 21, 2026, a gap of 40.1 percent.

The stock's market performance is therefore running ahead of the valuation reference used in that model. The dividend yield was 1.93 percent and the payout ratio was 50 percent on September 21, 2026, keeping income support visible while leaving the share price more dependent on continued earnings delivery.

Next report date is October 13

Johnson & Johnson is scheduled to report third quarter 2026 earnings on October 13, 2026, according to MarketBeat. The upcoming release will be measured against the second quarter revenue of USD 25.31 billion, earnings of USD 5.53 billion and EPS of USD 2.90.

Johnson & Johnson stock closed at USD 269.47 on the NYSE on September 21, 2026. The price and the 30.2 percent year-to-date gain show how much of the current valuation already rests on sustained operating performance.